Page last updated: 2024-09-03

4-bromo-a-23187 and halothane

4-bromo-a-23187 has been researched along with halothane in 2 studies

Compound Research Comparison

Studies
(4-bromo-a-23187)
Trials
(4-bromo-a-23187)
Recent Studies (post-2010)
(4-bromo-a-23187)
Studies
(halothane)
Trials
(halothane)
Recent Studies (post-2010) (halothane)
630514,369884235

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berggren, M; Iaizzo, PA; Melder, DC; Olsen, RA; Powis, G; Seewald, MJ1
Melder, DC; Olsen, RA; Powis, G; Schlager, JJ; Seewald, MJ1

Other Studies

2 other study(ies) available for 4-bromo-a-23187 and halothane

ArticleYear
Platelet-derived growth factor blocks the increase in intracellular free Ca2+ caused by calcium ionophores and a volatile anesthetic agent in Swiss 3T3 fibroblasts without altering toxicity.
    Toxicology letters, 1991, Volume: 55, Issue:1

    Topics: Aequorin; Calcimycin; Calcium; Cells, Cultured; Fibroblasts; Halothane; Ionomycin; Ionophores; Platelet-Derived Growth Factor

1991
High molecular weight dextran sulfate inhibits intracellular Ca2+ release and decreases growth factor-induced increases in intracellular free Ca2+ in Swiss 3T3 fibroblasts.
    Cancer communications, 1989, Volume: 1, Issue:3

    Topics: Arachidonic Acid; Arachidonic Acids; Arginine Vasopressin; Bradykinin; Calcimycin; Calcium; Cells, Cultured; Dextran Sulfate; Dextrans; Fibroblasts; Guanosine Triphosphate; Halothane; Heparin; Inositol 1,4,5-Trisphosphate; Mitogens; Molecular Weight; Platelet Activating Factor; Receptors, Cell Surface

1989